Clinical Trials on Advanced Adenoma in Finland
Total 144 results
-
Turku University HospitalTurku University of Applied SciencesCompletedAdvanced Cardiac Life SupportFinland
-
BayerCompletedAdvanced Recurrent Malignant Pleural Epithelioid Mesothelioma | Advanced Recurrent Malignant Peritoneal Epithelioid Mesothelioma | Advanced Recurrent Serous Ovarian Cancer | Advanced Pancreatic Ductal Adenocarcinoma (Optional, Dose Expansion, Not Initiated)United States, Sweden, Netherlands, United Kingdom, Finland
-
Tampere UniversityFinnish Prostate Cancer GroupUnknownPatients With T1-4 Advanced Prostate CancerFinland
-
Rhode Island HospitalBrown UniversityRecruiting
-
AstraZenecaTerminatedSubjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GCFinland
-
Helsinki University Central HospitalRecruitingSolid Tumor | Advanced Cancer | Haematological MalignancyFinland
-
Töölö HospitalTurku University Hospital; Tampere University Hospital; Jyväskylä Central Hospital and other collaboratorsRecruitingWrist Osteoarthritis | Scapholunate Advanced CollapseFinland
-
Bristol-Myers SquibbAgenus Inc.Active, not recruitingAdvanced CancerUnited States
-
TYK Medicines, IncRecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorUnited States
-
Turku University HospitalUniversity of TurkuActive, not recruitingBenign Prostatic Hyperplasia | Locally Advanced Prostate Cancer | Locally Recurrent Prostate Cancer | Localised Prostate CancerFinland
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, Australia
-
Agenus Inc.Active, not recruiting
-
PfizerCompletedColorectal AdenomaUnited States, Belgium, Italy, Portugal, Russian Federation, Canada, Singapore, Chile, Hong Kong, Taiwan, Germany, South Africa, Spain, China, Slovakia, Czech Republic, Israel, Hungary, Brazil, Netherlands, Australia, Denmark, Finland, Fran... and more
-
National Cancer Institute (NCI)CompletedLocally Advanced Pancreatic Neuroendocrine Tumor | Pancreatic Neuroendocrine Tumor G1 | Pancreatic Neuroendocrine Tumor G2 | Pancreatic Vipoma | Pancreatic Gastrinoma | Advanced Pancreatic Neuroendocrine TumorUnited States, Canada
-
Daiichi SankyoRecruitingAdvanced Solid Tumor | Metastatic Solid TumorUnited States, Japan
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, France, Spain, Switzerland
-
Chinese University of Hong KongChangi General Hospital; University Hospital AugsburgRecruitingColorectal Neoplasms | Colorectal Cancer | AdenomaHong Kong
-
Rhode Island HospitalCompletedChildren, Only | Tonsillar Hypertrophy | Adenoid HypertrophyUnited States
-
Repare TherapeuticsRoche Pharma AGActive, not recruitingAdvanced Solid TumorUnited States, Canada, Denmark, United Kingdom
-
Repare TherapeuticsDebiopharm International SARecruitingAdvanced Solid TumorUnited States, Canada, Denmark
-
Hoffmann-La RocheRecruitingAdvanced Solid TumorsUnited States
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingAdvanced Solid TumorsUnited States, Korea, Republic of, Australia
-
Eli Lilly and CompanyCompletedAdvanced CancerPuerto Rico, United States
-
Bristol-Myers SquibbActive, not recruitingAdvanced CancerItaly, Australia, United States, Spain, Romania, Argentina, Canada, Chile, Finland, Germany, Poland
-
MedImmune LLCCompletedA Study of MEDI5395 in Combination With Durvalumab in Participants With Select Advanced Solid TumorsAdvanced Solid TumorsUnited States, United Kingdom
-
Dartmouth-Hitchcock Medical CenterNational Institute of Nursing Research (NINR)Completed
-
Orion Corporation, Orion PharmaCompletedAdvanced Breast Cancer | Metastatic Breast Cancer | Castration-resistant Prostate Cancer | Prostate Cancer MetastaticFinland, France, Denmark
-
Regeneron PharmaceuticalsSanofiCompletedAdvanced Cancer | Advanced MalignanciesUnited States, Spain, Australia
-
Chugai PharmaceuticalRecruitingLocally Advanced or Metastatic Solid TumorsUnited States, Japan
-
Pyxis Oncology, IncRecruiting
-
Bristol-Myers SquibbTerminatedAdvanced CancerChile, United States, Argentina, Australia, Belgium, Canada, Finland, France, Germany, Israel, Italy, Netherlands, Norway, Poland, Romania, Spain, Switzerland
-
Bristol-Myers SquibbActive, not recruitingAdvanced or Metastatic Solid TumorsUnited States, Spain, Italy, Canada, Germany, United Kingdom, Denmark, Finland
-
Region Örebro CountyHelsinki University Central Hospital; Hospital Clinic of Barcelona; University... and other collaboratorsRecruitingQuality of Life | Advanced Breast Cancer | Metastatic Breast Cancer | Toxicity | Older PatientsSweden, Finland, Greece, Italy, Norway, Spain
-
Ningbo Newbay Technology Development Co., LtdRecruitingAdvanced Solid TumorUnited States, Spain, China, Korea, Republic of, France, United Kingdom
-
AbbVieActive, not recruitingAdvanced Solid Tumors CancerUnited States, Belgium, Finland, France, Italy, Japan, Korea, Republic of, Netherlands, Taiwan
-
Brown UniversityRhode Island HospitalCompletedPancreatic Cancer | Locally Advanced Pancreatic CancerUnited States
-
MedImmune LLCActive, not recruitingSelected Advanced Solid TumorsItaly, Spain, United States, France, Korea, Republic of, Taiwan, Australia, Netherlands, Portugal
-
AstraZenecaRecruitingAdvanced Solid Tumours That Are MTAP DeficientUnited States, Spain, Korea, Republic of, Australia, Japan, China, Netherlands, France
-
Astellas Pharma Global Development, Inc.Active, not recruiting
-
MedImmune LLCActive, not recruitingAdvanced Solid TumorsUnited States, Spain, Belgium, Italy, Korea, Republic of, Canada, Australia, Hungary, United Kingdom, France, New Zealand
-
Daiichi SankyoAstraZenecaRecruitingBreast Cancer | Advanced Solid TumorUnited States, Spain, Canada, France
-
BayerRecruitingLocally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene FusionUnited States, Austria, Denmark, Germany, Italy, Norway, Spain, United Kingdom, Brazil, Russian Federation, Switzerland, Taiwan, Canada, China, Australia, Greece, Belgium, Sweden, Korea, Republic of, France, Argentina, Finland, Ireland and more
-
Incyte CorporationRecruitingA Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsAdvanced Solid Tumors | Solid Tumors | Metastatic Solid TumorsUnited States, Spain, United Kingdom, France, Italy, Denmark, Switzerland
-
Jun Zhang, MD, PhDRhode Island HospitalRecruitingNSCLC, Stage III | Locally Advanced Lung CarcinomaUnited States
-
Venn Biosciences CorporationCompletedColorectal CancerUnited States
-
Novartis PharmaceuticalsCompletedCushing's DiseaseUnited States, Canada, Italy, Belgium, Turkey, Spain, France, Denmark, Germany, Greece, Israel, Argentina, China, Portugal, Brazil, Mexico, Finland, Poland
-
AbbVieCompletedAdvanced Solid Tumors CancerUnited States, Australia, Israel
-
Shanghai Junshi Bioscience Co., Ltd.Iqvia Pty Ltd; TopAlliance Biosciences, Inc.Active, not recruitingAdvanced MalignanciesUnited States
-
National Cancer Institute (NCI)Active, not recruitingCarcinoid Tumor | Functioning Pancreatic Neuroendocrine Tumor | Intermediate Grade Lung Neuroendocrine Neoplasm | Locally Advanced Pancreatic Neuroendocrine Tumor | Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm | Low Grade Lung Neuroendocrine Neoplasm | Metastatic Digestive... and other conditionsUnited States
-
PfizerTerminatedLocally Advanced or Metastatic Solid Tumors | Genes, BRCA 1United States, Belgium, Spain, Denmark, Japan, France, Italy, Netherlands, United Kingdom